Financhill
Back

Natera 10K Form

Buy
52

NTRA
Natera

Last Price:
$162.02
Seasonality Move:
-1.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NTRA News And Ratings

See the #1 stock for the next 7 days that we like better than NTRA

NTRA Financial Statistics

Sales & Book Value

Annual Sales: $1.1B
Cash Flow: $25M
Price / Cash Flow: 0
Annual Sales: $7.08
Price / Book: 24.37

Profitability

EPS (TTM): -1.76000
Net Income (TTM): $-214.7M
Gross Margin: $492.7M
Return on Equity: -26.45%
Return on Assets: -14.38%

Natera Earnings Forecast

Key Natera Financial Ratios

  • The Gross Profit Margin over the past 11 years for NTRA is 45.52%.
  • The Selling, General & Administrative Expenses for NTRA have been equal to 57.11% of Gross Profit Margin.
  • The Research & Development expenses have been 29.62% of Revenue.
  • The Interest Expense is -2.91% of Operating Income.
  • The Net Earning history of NTRA is -40.16% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 5 years.

Natera Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: NTRA
CUSIP: 632307
Website: natera.com

Debt

Debt-to-Equity Ratio: 0.42
Current Ratio: 4.39
Quick Ratio: 4.08

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NTRA Technical Analysis vs Fundamental Analysis

Buy
52
Natera (NTRA) is a Buy

Is Natera a Buy or a Sell?

  • Natera stock is rated a Buy
    The current Natera [NTRA] share price is $162.15. The Score for NTRA is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.